Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page’s interface revision/version indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check44 days agoChange DetectedThe site revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded site revision tag: v3.4.2. The government funding lapse notice was removed, and no study-specific content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a government funding notice about potential delays and directs users to opm.gov for status updates, and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.